NCT04056169View on ClinicalTrials.gov

Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

July 23, 2019

Study Completion Date

July 23, 2019

Conditions
Acute Coronary SyndromeCarotid Atherosclerotic Plaque With Inflammation
Interventions
DRUG

high-dose rosuvastatin

rosuvastatin 20 mg once a day for 6 months

DRUG

low-dose rosuvastatin plus ezetimibe

ezetimibe/rosuvastatin 10/5 mg once a day for 6 months

Trial Locations (2)

Unknown

Asan Medical Center, Seoul

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT04056169 - Comparison of High-dose Rosuvastatin Versus Low-dose Rosuvastatin Plus Ezetimibe on Carotid Plaque Inflammation in Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter